Collection: Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80% while improving article selection accuracy by 37%. It ensures faster, more reliable safety signal detection without sacrificing oversight, helping manage the overwhelming flow of data to protect patient safety.
-
Safety Shield Study for HYDROXYCHLOROQUINE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for HYDROXYZINE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for ICATIBANT
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for ILOPROST
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for IMIDACLOPRID
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for IMIPENEM CILASTATIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for IMIQUIMOD
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for IMMUNOGLOBULIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for INDOMETHACIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for INDOXACARB
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for INFLIXIMAB
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for INGENOL MEBUTATE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for INTERFERON ALFA B
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for INTRAVENOUS IMMUNOGLOBULIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for IPILIMUMAB
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for ISAVUCONAZOLE
Regular price From €800,00 EURRegular priceUnit price / per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...